BSE filing, BSE: 543914. Summary written from the filing by ALFA Finder's alert engine.
Swati Projects Ltd: key numbers
- Share price
- ₹46.98
- Market cap
- ₹47.45 Cr
- Revenue (annual)
- ₹34.23 Cr
- Net profit (annual)
- ₹6.06 Cr
- P/E (TTM)
- 6.6×Sector 19.7×
- Promoter holding
- 23.85%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swati Projects Ltd
All →Swati Projects Board Meeting Date
Swati Projects scheduled a board meeting for 06 Nov 2026 to consider director ShreeGopal Daga's resignation. The meeting has not yet been held.
Swati Projects Management Change
Swati Projects appointed Pooja Randar as Additional Director, designated Executive Professional Director, on October 23, 2026. She holds RBI approval and is not debarred by SEBI.
Swati Projects Board Meeting Date
Swati Projects intimated a board meeting for 23 October 2026 to consider other business. Trading window is closed from 1 October to 16 November 2026.
Swati Projects Annual General Meeting
Swati Projects Limited submitted proceedings for its 43rd Annual General Meeting held on September 30, 2026. Key agenda items included financial statement adoption and auditor appointments.
Swati Projects Annual General Meeting
Swati Projects Limited has issued a notice for its 43rd Annual General Meeting, scheduled to be held on 30th September 2026 via video conferencing.
Swati Projects Q1 FY27 Results: Turns Profitable, Net Profit ₹0.8 Cr
Swati Projects Ltd reported revenue from operations of ₹1.7 Cr (+183.3% YoY) and net profit of ₹0.8 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.8 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.